The good news about Multiple sclerosis (MS) research is that there seems to have been a major breakthrough in treatment, the bad news is that research regarding demyelinating disorders which includes MS seems to have slowed down (1) - finding a solution, a medical answer, that isn't politically approved of or one that is able to be easily patent protected may be the reason for the bad news.